Article

Covariate Adjusted Logit Model (CALM) for Generating Dose-Response Curves from Observational Data with Applications to Vaccine Effectiveness Trials

2025-02-21

Abstract excerpt

Establishing dose-response relationships from observational data is challenging due to confounding and sample selection bias. Standard causal methods adjust for confounding but typically require knowledge of covariate distributions in the target population—often via a well-defined probability sampling scheme. We propose the Covariate Adjusted Logit Model (CALM), which generalizes log-linear structural mean models...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5f6e28ea-6dfd-545b-acda-a8dccd06bea7
DOI: 10.1101/2025.02.18.24319273

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Covariate Adjusted Logit Model (CALM) for Generating Dose-Response Curves from Observational Data with Applications to Vaccine Effectiveness TrialsDOI 10.1101/2025.02.18.24319273Read

Simulation of synthetic health records for assessment of causal inference methods for vaccine efficacySemantic proximity Read

Some principles for using epidemiologic study results to parameterize transmission modelsSemantic proximity Read

serocalculator, an R package for estimating seroincidence from cross-sectional serological dataSemantic proximity Read

Causal analysis of absolute and relative risk reductionsSemantic proximity Read

<i>serosim</i>: an R package for simulating serological survey data arising from vaccination, epidemiological and antibody kinetics processesSemantic proximity Read

<i>serojump</i> : A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological dataSemantic proximity Read

Estimation and interpretation of vaccine efficacy in COVID-19 randomized clinical trialsSemantic proximity Read

Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host genetics.Semantic proximity Read

Leveraging pathogen sequence and contact tracing data to enhance vaccine trials in emerging epidemicsSemantic proximity Read

Analyzing Vaccine Trials in Epidemics with Mild and Asymptomatic InfectionSemantic proximity Read

Vaccine Efficacy at a Point in TimeSemantic proximity Read

Causal analysis of absolute and relative risk reductionsSemantic proximity Read